Paula Romina Nannini

The cytotoxic activity of Aplidin in chronic lymphocytic leukemia (CLL) is mediated by a direct effect on leukemic cells and an indirect effect on monocyte-derived cells

Pablo Elías Morande, Samanta Romina Zanetti, Mercedes Borge et al. · Investigational New Drugs · 2011 · 25 citations

Hematological Malignancy, Leukemic Cells, Medicine +10

The Expression of Sphingosine-1 Phosphate Receptor-1 in Chronic Lymphocytic Leukemia Cells Is Impaired by Tumor Microenvironmental Signals and Enhanced by Piceatannol and R406

Mercedes Borge, Federico Remes Lenicov, Paula Romina Nannini et al. · The Journal of Immunology · 2014 · 21 citations · Full text

Immunology, Cell Death, Immunotherapy +16

CXCL12 is a costimulator for CD4+ T cell activation and proliferation in chronic lymphocytic leukemia patients

Mercedes Borge, Paula Romina Nannini, Pablo Elías Morande et al. · Cancer Immunology Immunotherapy · 2012 · 20 citations · Full text

Hematological Malignancy, Immunology, Autoimmunity +6

CXCL12-induced chemotaxis is impaired in T cells from patients with ZAP-70-negative chronic lymphocytic leukemia

Mercedes Borge, Paula Romina Nannini, Jeremías G. Galletti et al. · Haematologica · 2010 · 18 citations · Full text

B cells inhibit the antitumor immunity against an established murine fibrosarcoma

Andrea Maglioco, Damián Machuca, María Noel Badano et al. · Oncology Letters · 2017 · 10 citations · Full text

T-regulatory Cell, Immunology, Immune Regulation +26